Elevance Health Inc.
Last updated September 27, 2026
Organization details
- Legal name
- Elevance Health Inc.
- Former names
- Anthem, Inc. Wellpoint, Inc
- Ownership
- Public
- Status
- Active
- SIC code
- 6324 — Hospital & Medical Service Plans
- Jurisdiction of incorporation
- Indiana
- Headquarters city
- Indianapolis
- Headquarters state / province
- Indiana
- Headquarters country
- United States
- Fiscal year end
- December
- Ticker symbol
- ELV
- Primary stock exchange
- NYSE
Identifiers
- SEC CIK
- 0001156039
- EIN
- 35-2145715
Board of directors
-
Amy W. Schulman · DirectorSince 2026
-
Antonio F. Neri · DirectorSince 2023
-
Bahija Jallal · DirectorSince 2023
-
Deanna D. Strable-Soethout · DirectorSince 2023
-
Elizabeth E. Tallett · DirectorSince 2023
-
Gail Boudreaux · Director · President and CEOSince 2023
-
Lewis Hay III · DirectorSince 2023
-
R. Kerry Clark · DirectorSince 2023
-
Ramiro G. Peru · DirectorSince 2023
-
Robert L. Dixon Jr. · DirectorSince 2023
-
Ryan M. Schneider · DirectorSince 2023
-
Steven H. Collis · DirectorSince 2025
-
Susan D. DeVore · DirectorSince 2023
Chief executives
Gail Boudreaux
· President and CEO
Dates unknown
Director election results
Annual meeting of May 13, 2026. Support is votes for as a share of votes for and against (or withheld). Below 80% is a clear protest.
-
96.9%
-
99.1%
Board connections
12 of this board's directors also sit on 18 other boards.
- via Ryan M. Schneider
- via Amy W. Schulman
- via Bahija Jallal
- via Steven H. Collis
- via Robert L. Dixon Jr.
- via Steven H. Collis
- via Amy W. Schulman
- via R. Kerry Clark
- via Antonio F. Neri
- via Bahija Jallal
- via Lewis Hay III
- via Elizabeth E. Tallett
- via Robert L. Dixon Jr.
- via Ramiro G. Peru
- via Susan D. DeVore
- via Gail Boudreaux
- via R. Kerry Clark
- via Susan D. DeVore
Insider trades
All notable trades →From SEC Forms 4 and 5. Open-market purchases and sales are highlighted; grants, option exercises and shares withheld for tax are routine.
- Bought, last 12 months
- $2,237,800
- 4 purchases by 3 insiders
- Sold, last 12 months
- $1,744,705
- 5 sales by 4 insiders
| Date | Insider | Transaction | Shares | Price | Value |
|---|---|---|---|---|---|
| Sep 3, 2026 | Wessling Erin M Officer (EVP & Chief Legal Officer) | Shares withheld for tax | −255 | $414.78 | $105,769 |
| Sep 2, 2026 | Craig Ryan R Officer (EVP & Chief HR Officer) | Shares withheld for tax | −144 | $405.84 | $58,441 |
| Sep 2, 2026 | Wessling Erin M Officer (EVP & Chief Legal Officer) | Shares withheld for tax | −94 | $405.84 | $38,149 |
| Jul 17, 2026 | Gail Boudreaux Director, Officer (President and CEO) | Open-market purchase | +680 | $366.41 | $249,159 |
| Jul 17, 2026 | Ramiro G. Peru Director | Open-market purchase | +1,000 | $366.05 | $366,050 |
| Jul 17, 2026 | Gail Boudreaux Director, Officer (President and CEO) | Open-market purchase | +2,045 | $368.25 | $753,071 |
| Jun 12, 2026 | Penczek Ronald W Officer (CAO & Controller) | Open-market sale | −369 | $403.16 | $148,766 |
| Jun 11, 2026 | Robert L. Dixon Jr. Director | Open-market sale | −151 | $401.77 | $60,667 |
| May 19, 2026 | Penczek Ronald W Officer (CAO & Controller) | Option exercise | +654 | $271.27 | $177,411 |
| May 19, 2026 | Penczek Ronald W Officer (CAO & Controller) | Option exercise | +877 | $311.48 | $273,168 |
| May 19, 2026 | Penczek Ronald W Officer (CAO & Controller) | Open-market sale | −1,531 | $403.13 | $617,192 |
| May 13, 2026 | Deanna D. Strable-Soethout Director | Grant or award | +563 | — | — |
| May 13, 2026 | Amy W. Schulman Director | Grant or award | +563 | — | — |
| May 13, 2026 | Ryan M. Schneider Director | Grant or award | +563 | — | — |
| May 13, 2026 | Ramiro G. Peru Director | Grant or award | +563 | — | — |
Reviews (0)
Sign in to write a review.
No reviews yet. Be the first to write one.